Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Search Results for 已驗證的CTAL-TTA_Syll19_4.0 考題資源和資格考試領導者和可靠的CTAL-TTA_Syll19_4.0:ISTQB Certified Tester Advanced Level - Technical Test Analyst (V4.0) 🌸 《 www.newdumpspdf.com 》是獲取⮆ CTAL-TTA_Syll19_4.0 ⮄免費下載的最佳網站CTAL-TTA_Syll19_4.0熱門認證

697 posts found

Contact Us

...866.646.2838 Drug Information Line DrugInformation@healthesystems.com Submit a question online Sales Inquiry 800.921.1880 info@healthesystems.com Careers 800.921.1880 View Our Careers Page  careers@healthesystems.com Corporate Information 800.921.1880 communications@healthesystems.com Media Inquiries 813-367-2898 jbleile@healthesystemsCalifornia P&T Committee to Address MTUS Updates and Ibuprofen Price Outliers
The California Pharmacy and Therapeutic (P&T) Committee will hold a hybrid meeting on April 15, 2026 from 12:30 PM to 2:30 PM PST to discuss updates to the MTUS drug...
Read More

California P&T Committee Reviews Topical Analgesics 

Healthesystems attended the California Pharmacy & Therapeutics (P&T) Committee on July 16th, where members reviewed topical analgesics and worked toward developing recommendations for the state’s workers’ compensation formulary. These meetings...
Read More

Worker's Comprehensive

Workers’ Comprehensive News and views in workers’ comp Important news in workers’ comp delivered to your inbox Search Workers' Comprehensive Articles...
Read More

New Mexico Workers’ Compensation Administration Publishes Annual Report

The New Mexico Workers’ Compensation Administration published their 2024 Annual Report, highlighting system performance and claim trends. According to the report, medical-only claims have fluctuated significantly since 2018, starting at...
Read More

Tracking Sub-Regulatory Changes in Workers’ Comp

Risk and Insurance magazine recently published an article on the challenges of tracking and managing the various regulatory developments that affect workers’ comp across the country. While many workers’ comp...
Read More

When Demand Exceeds Supply: Older Patients and Fewer Physicians in Workers' Comp

The looming physician shortage and how to meet the challenge in workers' comp...
Read More

The Patient Experience in Perspective: Applying Empathy to the Work Comp Claims Process

Understanding patients’ pain points with comp can lead to insights that improve program outcomes...
Read More

Live Better, Heal Better: Employee Wellness in Workers' Comp

Workers’ comp continues to grow more complex as the scope of care expands to a greater, more holistic view of patient wellness. Health concerns outside of a claim can significantly...
Read More

Tennessee: Formulary and UR Updates from the Medical Advisory Committee Meeting

On September 23rd, Healthesystems attended the Tennessee Medical Advisory Committee (MAC) meeting to hear key updates impacting the state’s workers’ comp system. The Bureau of Workers’ Compensation (BWC) Medical Director...
Read More

California P&T Committee to Discuss Pharmacy Fee Schedule

...tool Drug list utilization rates. Meeting materials are available on the P&T Committee webpage, and the DWC encourages public comments on the formulary drug list to be sent to Formulary@dir.ca.gov....
Read More

NCCI Explores Economic Impacts of COVID-19 on Workers’ Comp

The National Council on Compensation Insurance (NCCI) published a new report on the economic impact of Coronavirus on workers’ comp, exploring employment, business closure and furloughs, injury frequency, injury severity,...
Read More

Triple Threat: Healthcare Fraud, Waste and Abuse in Workers’ Comp

Fraud, waste, and abuse (FWA) is an unfortunate fact of life for workers’ compensation payers who must contend with a variety of issues that drive up costs, compromise care for...
Read More

Specialty Drugs to Watch in Workers’ Comp: Infusibles and Injectables

Specialty drugs continue to comprise a growing portion of costs in workers’ comp – anywhere from 5-8% of total pharmacy spend, according to recent industry data. In fact, individual therapies...
Read More
1 2 3 4 5 23 24 25 26 27 43 44 45 46 47
lockmap-markermagnifiercrossmenuarrow-rightcross-circle